Development of a novel AAV-based gene therapy in combination with tolerogenic nanoparticles for sustained treatment of ornithine transcarbamylase deficiencyG. De Sabbata,F. Boisgerault,C. Guarnaccia,G. Bortolussi,F. Collaud,A. Iaconcig, M. L. S. Sola, S. Charles,C. Leborgne,E. Nicastro,P. Ilyinskii,T. K. Kishimoto,L. D'Antiga,F. Mingozzi,A. F. MuroHUMAN GENE THERAPY（2018）引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
